German Medtechs Say MDR Ball Is In EU’s Court, Plus DRG Changes and ESG Reactions
Jury is out on planned market access changes affecting German and EU medtech industries
Marc-Pierre Möll, CEO of German medtech-industry association BVMed, is hoping for a more collaborative year in 2023 after the health ministry came out with proposals to change the DRGs system and the EU finally conceded that its unhelpful MDR timetable was riding roughshod over the wellbeing of patients.
You may also be interested in...
At last! After an intense year of lobbying by the medtech sector decision-makers have agreed to crisis management action for the EU’s Medical Device Regulation.
DRGs are not doing what they were conceived to, ambulatory care needs more support and health care delivery across the country must be unburdened from bureaucracy, health minister Karl Lauterbach told the German hospital congress meeting during Medica 2022.
Germany’s medtech industry is gearing up for a new supply chain law coming into force in January 2023.